Insight Guru says Health Care dominates mid-cap 52-week highs list, with 11 of 19 names at new peaks

Insight Guru flagged 19 Russell 3000 mid-cap stocks at 52-week highs, led by Biogen at about $32.61 billion market value.

Health Care dominated the screen with 11 of 19 names, signaling concentrated leadership in the sector.

Fundamentals diverged: Labcorp revenue rose 6.4% with an 11.4% operating margin; Quest revenue gained 9.9% with a 14.1% margin.

Biogen revenue grew 0.3% despite a 19.3% operating margin, suggesting price strength is not uniformly tied to top-line growth.

The analysis framed new highs as a research trigger, urging checks on whether financial performance supports valuations.